in a recent O-GlcNAc profiling screen utilizing chemoenzymatic labeling and 48 bioorthogonal conjugation. We demonstrate that MYPT1 is O-GlcNAcylated at T577, 49 S585, S589 and S601, which antagonizes CDK1-dependent phosphorylation at S473, 50 subsequently attenuating the association between MYPT1 and Plk1, and promoting 51 PLK1 activity. Thus under high O-GlcNAc, Plk1 is untimely activated, conducive to 52 inopportune centrosome separation and disrupting the cell cycle. We propose that too 53 much O-GlcNAc is equally deleterious as too little O-GlcNAc, and a fine balance 54 between the OGT/OGA duo is indispensible for successful mitotic divisions. 55
INTRODUCTION 56
The centrosomes are the primary microtubule-organizing centers that nucleate 57 the mitotic spindle apparatus to ensure subsequent faithful sister chromatid 58 segregation during mitosis. The centrosome cycle is tightly coordinated with other 59 cell cycle events 1 , and its aberrancy could culminate in chromosome segregation 60 defects and aneuploidy 2 . The entire centrosome cycle encompasses centrosome 61 duplication during S phase, disjunction in late G2 and further separation during 62 prophase or prometaphase, and eventual segregation into the two daughter cells. 63
Centrosomes duplicate in concomitant with DNA replication, after which the 64 sister centrosomes are glued together by two proteinaceous linkers, c-Nap1 and 65 rootletin 3,4 , as well as other components such as Cep68, Cep215 and LRRC45 5 . 66 C-Nap1, a large coiled-coiled protein, links rootletin to the centrioles so that the 67 centrosome pair is joined by fibrous polymers 3 . In late G2, the Never In Mitosis 68 (NIMA)-related serine/threonine kinase Nek2A phosphorylates and displaces c-Nap1 69 and rootletin, leading to disjoint centrosomes 6 . Centrosomal accumulation of Nek2A 70 is mediated by the Hippo pathway, among which sterile 20-like kinase 2 (Mst2) and 71 Salvador (Sav1) play critical roles. In particular, Mst2 phosphorylates and activates 72 Nek2A 7 . Upstream of Mst2 is the mitotic master kinase, Polo-like kinase 1 (PLK1) 8 . 73
Following centrosome disjunction, the kinesin Eg5 accounts for centrosome 74 positioning in the beginning of M phase. Cyclin-dependent kinase 1 (Cdk1) 75 phosphorylates and activates Eg5 at T927 by stimulating the engagement between 76 Eg5 and microtubules 9 . Independently, centrosomal localization of Eg5 requires 77 PLK1 10 , which activates the NIMA-family kinase Nek9, leading to Eg5 78 phosphorylation at S1033 by the Nek9/6/7 complex 11 . Phosphorylated Eg5 then binds 79 centrosomal Targeting Protein for Xenopus kinesin-like protein 2 (TPX2), which is 80 also mediated by Nek9 12 . Besides mitosis, Eg5 also governs centrosome dynamics 81 during interphase 10 . Hence, the centrosomal role of Plk1 is two-fold : centrosome 82 disjunction via the PLK1-Mst2-Nek2A signaling cascade, and centrosome separation 83 through PLK1-Nek9/6/7-Eg5 13 . 84
Besides centrosomes, PLK1 also orchestrates a multitude of cell cycle events, 85
including replication, mitotic entry, chromosome segregation and cytokinesis 4,14-16 . It 86 contains an N-terminal kinase domain and a C-terminal polo-box binding domain 87 (PBD). Phosphorylation of PLK1 at T210 at the T-loop is mediated by the Aurora 88 A-Bora complex 17 , resulting in dissociation of PBD from the kinase domain and thus 89 activating PLK1. Dephosphorylation of PLK1 is modulated by the protein 90 phosphatase 1 cβ (PP1cβ), targeted by the myosin phosphatase targeting subunit 1 91 (MYPT1) 18 
O-GlcNAc promotes aberrant centrosome separation via PLK1 120
Previously, both OGT and OGA overproduction has been linked with multi-polar 121 spindle 31 . We sought to identify whether O-GlcNAc could also be linked with 122 centrosome dynamics. Strikingly, when HeLa cells were treated with TMG (OGAi), 123 the inter-centrosomal distance was significantly augmented four-fold ( Fig. 1A) , 124 reminiscent of the phenotype of Nek2A overexpression or over-activation 4,32 . As the 125 centrosome cycle is tightly governed by PLK1, we attempted to inhibit PLK1. When 126 BI2536 (PLK1i) was adopted in conjuncture with TMG, the centrosomal distances 127 shortened considerably ( Fig Previous investigation has identified the inactivating phosphatase of PLK1 is 134 PP1cβ, which is targeted by MYPT1 18 . Intriguingly, MYPT1 is O-GlcNAcylated 26 . 135 Therefore we reasoned that O-GlcNAc might exert its effect through MYPT1. 136
First, we validated the interaction between MYPT1 and OGT through 137 biochemical assays. As shown in Fig. 2A , GST-OGT pulled-down HA-MYPT1 from 138 cell extracts. Then both OGT and MYPT1 proteins were purified from E. coli. Upon 139 incubation, His-OGT pulled-down GST-MYPT1 ( Fig. 2B ), suggesting that the 140 interact is direct. 141
Then we mapped which domain of MYPT1 interacts with OGT. As MYPT1 is a 142 relative large protein, we constructed several fragments of MYPT1 as previously Since CDK1 phosphorylates MYPT1 at S473 during mitosis and creates a 162 binding motif between MYPT1 and the PBD of PLK1 18 , we surmised that O-GlcNAc 163 of MYPT1 might interplay with pS473. To address this possibility, we used a 164 phospho-specific antibody targeting pS473 that has been previously described and 165 utilized 25 . 166
Then the WT and 4A plasmids are compared for the pS473 levels, and it is 167 significantly bolstered in the 4A mutant ( Fig. 4B ). When Noc was used to 168 synchronize cells in the M phase, O-GlcNAc levels decreased while pS473 levels 169 arose ( Fig. 4C ). As pS473 is mediated by CDK1, we adopted RO-3306 again, and 170 observed that RL2 levels decreased while pS473 levels increased in the 171 RO-3306-treated cells (Fig.4C ). This is consistent with our conjecture that O-GlcNAc 172 antagonizes pS473. Lastly, we utilized the 5S-G inhibitor for OGT 29 , and 5S-G 173 treatment substantially boosted pS473 levels of transfected HA-MYPT1( Fig. 4D ). We 174 also examined the effects of 5S-G on endogenous MYPT1. Noc treatment enhanced 175 pS473 levels, and Noc plus 5S-G elevated pS473 markedly ( As phosphorylated MYPT1 binds with PLK1-PBD 18 , we adopted GST 187 pulldown experiments using PLK1-PBD, and GST-PLK1-PBD modestly increased 188 binding with HA-MYPT1-4A ( Fig. 5B ). Then we employed FL-PLK1. When we 189 directly utilized the 4A mutant to coIP PLK1, the interaction between MYPT1 and 190 PLK1 substantially upregulated ( Fig. 5C ).When His-PLK1 was applied in pulldown 191 assays, 4A again manifested more robust association with PLK1( Fig. 5D ). In sum, the 192 binding between PLK1 and MYPT1 was abolished during high O-GlcNAc. 193
194

O-GlcNAcylation of MYPT1 enhances PLK1 activity 195
As the MYPT1 associates PLK1 to target PP1cβ to dephosphorylate and 196 deactivate PLK1 18 , stronger affinity could signify less activity. We took advantage of 197 the IP-phosphatase assay to examine PLK1 activity 22,24 . Cells were transfected with 198
Flag-MYPT1 and treated with Noc. Cells were also supplemented with TMG + Glu to 199 enrich for O-GlcNAc or not treated. When the anti-FLAG immunoprecipitates were 200 incubated with recombinant PLK1, the relative low O-GlcNAc group efficiently 201 dephosphorylated PLK1, as detected by IB with PLK1-pT210 antibodies, but not the 202 high O-GlcNAc group (Fig. 6A) . 203 MYPT1-4A mutants were then directly exploited in the IP-phosphate assay. In 204 the absence of Noc, MYPT1-WT decreased PLK1 pT210 levels, and the MYPT1-4A 205 completely abolished PLK1-pT210 levels (Fig. 6B ). This is consistent with our results 206 in Fig. 5C -D that MYPT1-4A partners with PLK1 in the absence of Noc treatment. 207
Collectively, our biochemical assays suggest that O-GlcNAcylated MYPT1 disjoins 208 PLK1 and promotes its kinase activity. 209
210
MYPT1-4A Suppresses the TMG-induced centrosome disjunction defects 211
Since the aforementioned results suggest that MYPT1 O-GlcNAcylation is a 212 pivotal regulator in centrosome separation, we undertook shMYPT1 to knockdown 213 endogenous MYPT1 (Fig. 7A) , so that the effects of MYPT1-4A could be directly 214 measured and observed after TMG incubation. As shown in Fig. 7B , the premature 215 centrosome separation phenotype is discernable in the shMYPT1 cells that bears 216 MYPT1-WT plasmids. But in the cells transfected with MYPT1-4A plasmids, the 217 aberrancy is suppressed (Fig. 7C ), in line with previous reports that PLK1 218 sequestration culminates in duplicated but unseparated centrosomes 37,38 . Taken 219 together, the 4A mutant fails to show the untimely centrosome separation phenotype, 220 probably due to PLK1 suppression. 221 222 223
DISCUSSION 224
In this study, we identify that O-GlcNAc regulates centrosome separation 225 through the MYPT1-PLK1 complex. We pinpoint the major O-GlcNAcylated sites of 226 MYPT1 to be S564, S566, T570 and S578 in human cells, and further delineate that 227 O-GlcNAc antagonizes pS473, hinders MYPT1-PLK1 association, thus boosting 228 PLK1 activity and hence centrosome disjunction (Fig. 7D ). When MYPT1 fails to be 229 O-GlcNAcylated, as in the MYPT1-4A mutant, PLK1 activity is dampened (Fig. 6B) . 230 MYPT1 is one of the most abundant O-GlcNAcylated proteins, and its 231 modification sites have been unveiled time and again in distinct proteomic studies 232 34, 39, 40 . Perhaps O-GlcNAc sites might not be conserved between humans and mice. 233 MYPT1 is found to be O-GlcNAcylated at S564, S566, T570 and S578 by mass 234 spectrometry in the mouse brain 40 , but our data show in HeLa cells O-GlcNAc occurs 235 in T577, S585, S589 and S601. Previously, p53 is identified to be O-GlcNAcylated at 236 S149 41 , which is not conserved in mice either. The same also holds true for 237 phosphorylation. For instance, Ataxia-telangiectasia mutated (ATM), a vital sensor 238 protein for DNA damage signaling, is phosphorylated at S1981 and then activated in 239 humans, but mutation of S1987 (the mouse equivalent) does not hinder ATM function Our results indicate that O-GlcNAcylated MYPT1 attenuates interaction with 257 PLK1 and thus promotes PLK1 activity. It is intriguing that overall PLK1 pT210 258 levels remain unaltered in OGT or OGA overproduction cells 31,46 . We did not detect 259 discernable difference either, in cells supplemented with TMG plus Glucose (data not 260 shown). This may seem paradoxical at first, but considering the versatile roles of 261 PLK1 during mitosis 4,14-16 , we could entertain the possibility that only a small pool of 262 PLK1 is regulated by MYPT1. First, although the overall activity of PLK1 is 263 upregulated during mitosis, CDK1 actually dampens PLK1 activity via MYPT1 in a 264 mitosis-specific fashion 18 . Secondly, the pool of PLK1 responsible for 265 kinetochore-microtubule attachment actually contains low PLK1 kinase activity 266 during metaphase so that microtubules could be dynamic 48 
